Tilray Brands, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $TLRY in the last 30 days.
See all $TLRY insider activity →Tilray Brands (TLRY) reported Q1 fiscal 2027 earnings, with revenue up 23% to $56.1M, but cannabis revenue fell 13% YoY. Cash burn spiked to $16.5M, and operating expenses rose 83% YoY. The company attributes growth to acquisitions, but investors may be concerned about organic growth and cash flow.
Tilray Brands (TLRY) has lost over 90% of its market value in five years, trading near $4 per share. The company reported Q1 2027 revenue of $257.1M, up 23% YoY, but cannabis revenue declined 13% YoY. Tilray posted a net loss of $0.32 per share. The cannabis industry's outlook remains uncertain, and even federal legalization may not solve Tilray's financial struggles.
Canaccord Genuity kept a Hold rating on Tilray Brands with a $4 price target, suggesting 11.4% upside from the Oct 8 close. Tilray reported $257.1M revenue, missing estimates due to cannabis segment challenges and international pricing pressures. BrewDog contributed $55.9M to the beverage segment, showing growth.
Over the past 7 days, AlphAI's AI scored 24 news stories mentioning TLRY (Tilray Brands, Inc.). Coverage has skewed bearish: 5 bullish, 6 neutral, and 13 bearish.
Recent TLRY coverage spans earnings, market movers and financial news.
Earnings miss on cash flow and expenses likely pressures the stock.
Negative pressure as earnings miss expectations and ongoing losses.
Analyst downgrade to Hold with modest upside target may pressure the stock.
Strong revenue growth may support short‑term upside.
Record revenue and margin expansion offset a net loss, while guidance remains unchanged.
AlphAI scores every news story that mentions TLRY with an AI model for sentiment and relevance, and aggregates insider trades from Tilray Brands, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Tilray Brands (TLRY) reported Q1 fiscal 2027 earnings, with revenue up 23% to $56.1M, but cannabis revenue fell 13% YoY. Cash burn spiked to $16.5M, and operating expenses rose 83% YoY. The company attributes growth to acquisitions, but investors may be concerned about organic growth and cash flow.
2 min readTilray Brands (TLRY) has lost over 90% of its market value in five years, trading near $4 per share. The company reported Q1 2027 revenue of $257.1M, up 23% YoY, but cannabis revenue declined 13% YoY. Tilray posted a net loss of $0.32 per share. The cannabis industry's outlook remains uncertain, and even federal legalization may not solve Tilray's financial struggles.
2 min readCanaccord Genuity kept a Hold rating on Tilray Brands with a $4 price target, suggesting 11.4% upside from the Oct 8 close. Tilray reported $257.1M revenue, missing estimates due to cannabis segment challenges and international pricing pressures. BrewDog contributed $55.9M to the beverage segment, showing growth.
1 min readLevi's (LEVI) shares fell 3.7% after softer DTC sales growth, though earnings beat estimates. Starbucks (SBUX) dropped 3% amid takeover speculation. Argenx (ARGX) fell 15% after discontinuing a drug trial. Haemonetics (HAE) rose 13% on CSL's device rollout plan. Tilray (TLRY) reported record revenue. Wolfspeed (WOLF) gained 11% on a $1.5B US DoD loan. Palantir (PLTR) rose 3% after a Goldman upgrade. Globalfoundries (GFS) rose 3% on a $2B TSMC deal. Helen of Troy (HELE) raised its profit outlook.
3 min readTilray Brands reported Q1 2027 revenue of $257.1M, up 23% YoY, and gross profit of $77.5M with a 30% margin. The company had a net loss of $40.0M but reaffirmed adjusted EBITDA guidance of $68M-$75M. Beverage and international segments showed growth, while cannabis margins improved.
2 min readTilray Brands, Inc. (TLRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution First-Quarter Results
2 min readTilray Brands reported that BrewDog's UK retail sales for Punk IPA and Hazy Jane increased 2.87 times compared to the same period last year, driven by new campaigns, over 9,000 new distribution points, and eight new on-trade partnerships.
1 min readTILRAY ($TLRY) is set to report Q1 2027 earnings on October 8th, with analysts expecting $273.92M revenue and -$0.19 EPS. Insiders traded $TLRY 4 times in the past 6 months, with 3 purchases and 1 sale. Hedge funds have mixed activity, with 96 adding shares and 74 decreasing positions. Q4 2026 revenue was $281.7M, up 25.47% YoY.
1 min readTD Securities reduced its price target for Tilray Brands to C$6.50 from C$6.75, a 3.7% decrease, while maintaining a Buy rating. The company is set to report Q1 fiscal 2027 results on October 8, with investors focusing on revenue, margins, and cash conversion. International cannabis demand and beverage performance will be key factors.
1 min readTilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) will release its first fiscal quarter 2026 financial results on October 8, 2026, before market open. The company will host a live conference call at 8:30 AM ET to discuss the results. Tilray operates in cannabis, beverage, wellness, and entertainment industries across multiple countries.
1 min read
